{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "The state panel that runs Oregon's health plan voted today to spend tax money to pay for doctor-assisted suicides of terminally ill poor people. The panel, the Health Services Commission, voted 10 to 1 that delivering lethal doses of prescription drugs should be covered as a ''medical service'' for the 270,000 low-income residents covered under the state's health plan. The plan covers the poor who are unable to obtain health coverage and is the state's effort to supplement Medicaid to provide universal health care.", "headline": {"main": "Oregon Lets State Pay For Suicides"}, "abstract": "State panel that runs Oregon's health plan votes to spend tax money to pay for doctor-assisted suicides of terminally ill poor people (S)", "print_page": "10", "word_count": "274", "_id": "4fd215708eb7c8105d78ee2f", "snippet": "The state panel that runs Oregon's health plan voted today to spend tax money to pay for doctor-assisted suicides of terminally ill poor people.    The panel, the Health Services Commission, voted 10 to 1 that delivering lethal doses of prescription...", "source": "AP", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1998/02/27/us/oregon-lets-state-pay-for-suicides.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "OREGON"}, {"name": "subject", "value": "DEATH AND DYING"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "SUICIDES AND SUICIDE ATTEMPTS"}], "byline": null, "document_type": "article", "pub_date": "1998-02-27T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "A day after a ruling against medical marijuana clubs took effect statewide, a judge today granted a state request for an injunction against the Cannabis Cultivators Club here. The club said its operations would be unaffected. ''We are abiding by the law,'' said J. David Nick, a lawyer for Dennis Peron, founder of the club and author of Proposition 215, the medical marijuana initiative approved by voters in November 1996. Mr. Nick said the club's continued distribution of marijuana to patients complied with a state appeals court ruling and the injunction issued today.", "headline": {"main": "National News Briefs; Court Issues Injunction Against Marijuana Club"}, "abstract": "San Francisco judge grants state request for injunction against Cannabis Cultivators Club in San Francisco, day after ruling against medical marijuana clubs took effect statewide; club says its operations will be unaffected (S)", "print_page": "12", "word_count": 187, "_id": "4fd1f7cd8eb7c8105d7536db", "snippet": "A day after a ruling against medical marijuana clubs took effect statewide, a judge today granted a state request for an injunction against the Cannabis Cultivators Club here. The club said its operations would be unaffected.    ''We are abiding by...", "source": "AP", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1998/02/27/us/national-news-briefs-court-issues-injunction-against-marijuana-club.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "SAN FRANCISCO (CALIF)"}, {"name": "glocations", "value": "CALIFORNIA"}, {"name": "organizations", "value": "CANNABIS CULTIVATORS CLUB"}, {"name": "subject", "value": "ORGANIZATIONS, SOCIETIES AND CLUBS"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "DRUG ABUSE AND TRAFFIC"}, {"name": "subject", "value": "MARIJUANA"}], "byline": null, "document_type": "article", "pub_date": "1998-02-27T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "After reports of depression and a few suicides among users of the powerful acne drug Accutane, the manufacturer said today that doctors should watch Accutane patients carefully for signs of depression. The drug's manufacturer, Hoffmann-La Roche, said that there was no proof that Accutane, which is taken in capsules, caused the problems, and that people with severe acne were at risk for depression anyway.", "headline": {"main": "An Acne Drug and Depression May Be Linked"}, "abstract": "Hoffmann-La Roche, after reports of depression and few suicides among users of powerful acne drug Accutane, says that doctors should watch Accutane patients carefully for signs of depression (S)", "print_page": "15", "word_count": "347", "_id": "4fd20ae78eb7c8105d77841a", "snippet": "After reports of depression and a few suicides among users of the powerful acne drug Accutane, the manufacturer said today that doctors should watch Accutane patients carefully for signs of depression.    The drug's manufacturer, Hoffmann-La Roche,...", "source": "AP", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1998/02/26/us/an-acne-drug-and-depression-may-be-linked.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "HOFFMANN-LA ROCHE INC"}, {"name": "subject", "value": "ACNE"}, {"name": "subject", "value": "ACCUTANE (DRUG)"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "MENTAL HEALTH AND DISORDERS"}, {"name": "subject", "value": "DEPRESSION (MENTAL)"}, {"name": "subject", "value": "SUICIDES AND SUICIDE ATTEMPTS"}], "byline": null, "document_type": "article", "pub_date": "1998-02-26T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Four years ago, Daniel Cohen dazzled the scientific world when his Paris lab roughed out the first comprehensive map of all human chromosomes. This year, Dr. Cohen will complete a far more detailed map and attach it to a tantalizing business proposition: use the map to predict the responses of individual patients to new drugs. The proposition comes with a new buzzword, pharmacogenomics, and the potential to save pharmaceutical companies hundreds of millions of dollars at a clip. That is the amount they can spend developing a potential new drug, only to see it fail because of unexpected side effects or a poor response rate among patients. Dr. Cohen's company, Genset S.A., believes it can improve the odds of success, and reap tens of millions of dollars in fees for the service.", "headline": {"main": "INTERNATIONAL BUSINESS: Smoother Road From Lab to Sales; DNA Technique Aims to Predict Whom a Drug Will Benefit"}, "abstract": "Human Genome Project, the 15-year global effort to map human genetic code, is spawning new businesses in field of pharmacogenomics that hope to better predict effectiveness and side effects of drugs; such businesses could save drug makers hundreds of millions of dollars in development costs; Dr Daniel Cohen, chief genomics officers at Genset SA, says effort will limit patients' exposure to ineffective or harmful drugs and cut health care costs; critics cite concerns about whether process will work and whether insurers will use data to deny new drugs to some patients; table; photo (M)", "print_page": "1", "word_count": 1738, "_id": "4fd204e48eb7c8105d76cad8", "snippet": "Four years ago, Daniel Cohen dazzled the scientific world when his Paris lab roughed out the first comprehensive map of all human chromosomes. This year, Dr. Cohen will complete a far more detailed map and attach it to a tantalizing business...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1998/02/25/business/international-business-smoother-road-lab-sales-dna-technique-aims-predict-whom.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "COHEN, DANIEL"}, {"name": "organizations", "value": "GENSET SA"}, {"name": "subject", "value": "HUMAN GENOME PROJECT"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "GENETICS AND HEREDITY"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "FINANCES"}, {"name": "subject", "value": "INDUSTRY PROFILES"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1}], "original": "By LAWRENCE M. FISHER"}, "document_type": "article", "pub_date": "1998-02-25T00:00:00Z", "section_name": "Health; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "Week in Review Desk", "lead_paragraph": "IT would be ''absolutely impermissible'' for the Government to block lawsuits against the tobacco companies, David A. Kessler, the former Commissioner of Food and Drugs, said last week. ''There should be no concessions to this industry.'' In Congress, where the companies have about as much political support as an international drug cartel, Dr. Kessler's stance is clearly the prevailing one. ''Their effort to target 14-year-olds is frankly reprehensible,'' said Speaker Newt Gingrich. ''I think that they are weaker than they have ever been in this city, and I think that there is virtually no sentiment for in any way listening favorably to the tobacco companies.''", "headline": {"main": "The Nation: Tobacco Talks; Congress Mulls a Commercial Break"}, "abstract": "David E Rosenbaum article notes that dominant view of lawyers and academics who specialize in First Amendment is that Congress cannot ban tobacco industry ads that target teen-agers because to do so would violate industry's right to free speech; cites contention of industry lawyer Meyer Koplow that tobacco companies will not agree to modify their relentless ad campaigns unless Congress enacts law that gives them considerable protection from damage suits; photos (M)", "print_page": "5", "word_count": 925, "_id": "4fd204db8eb7c8105d76c338", "snippet": "IT would be ''absolutely impermissible'' for the Government to block lawsuits against the tobacco companies, David A. Kessler, the former Commissioner of Food and Drugs, said last week. ''There should be no concessions to this industry.''    In...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1998/02/22/weekinreview/the-nation-tobacco-talks-congress-mulls-a-commercial-break.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "KOPLOW, MEYER"}, {"name": "subject", "value": "ADVERTISING"}, {"name": "subject", "value": "CHILDREN AND YOUTH"}, {"name": "subject", "value": "SUITS AND LITIGATION"}, {"name": "subject", "value": "SMOKING AND TOBACCO"}, {"name": "subject", "value": "FREEDOM OF SPEECH"}], "byline": {"person": [{"firstname": "David", "middlename": "E.", "lastname": "ROSENBAUM", "rank": 1, "role": "reported", "organization": ""}], "original": "By DAVID E. ROSENBAUM"}, "document_type": "article", "pub_date": "1998-02-22T00:00:00Z", "section_name": "Week in Review"}], "meta": {"hits": 5, "offset": 0, "time": 70}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}